D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Molecular Biology D-index 49 Citations 7,784 204 World Ranking 1804 National Ranking 2

Research.com Recognitions

Awards & Achievements

Member of the European Molecular Biology Organization (EMBO)

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • DNA
  • Enzyme

The scientist’s investigation covers issues in Cystic fibrosis transmembrane conductance regulator, Cystic fibrosis, Cell biology, Mutation and Endoplasmic reticulum. Her Cystic fibrosis transmembrane conductance regulator research is multidisciplinary, incorporating perspectives in Molecular biology, Clinical trial, Surrogate endpoint and Transmembrane protein. Her Cystic fibrosis research entails a greater understanding of Internal medicine.

Her Cell biology study incorporates themes from Proteome, Biochemistry, Caenorhabditis elegans and Genetic screen. Her work deals with themes such as Apical membrane and Protein folding, which intersect with Endoplasmic reticulum. Margarida D. Amaral has included themes like Disease and Allelic heterogeneity in her Genotype study.

Her most cited work include:

  • Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene (390 citations)
  • Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene (390 citations)
  • Transcription-dependent spatial arrangements of CFTR and adjacent genes in human cell nuclei (238 citations)

What are the main themes of her work throughout her whole career to date?

Margarida D. Amaral mainly investigates Cystic fibrosis, Cystic fibrosis transmembrane conductance regulator, Cell biology, Molecular biology and Endoplasmic reticulum. Her Cystic fibrosis study is focused on Internal medicine in general. While the research belongs to areas of Internal medicine, Margarida D. Amaral spends her time largely on the problem of Endocrinology, intersecting her research to questions surrounding Genotype-phenotype distinction.

Her Cystic fibrosis transmembrane conductance regulator research is classified as research in Genetics. Her Cell biology research is multidisciplinary, incorporating elements of Regulator, Biochemistry and Transmembrane protein. Margarida D. Amaral has researched Endoplasmic reticulum in several fields, including Chaperone and Protein folding.

She most often published in these fields:

  • Cystic fibrosis (61.32%)
  • Cystic fibrosis transmembrane conductance regulator (46.23%)
  • Cell biology (37.26%)

What were the highlights of her more recent work (between 2017-2021)?

  • Cystic fibrosis (61.32%)
  • Cell biology (37.26%)
  • Cystic fibrosis transmembrane conductance regulator (46.23%)

In recent papers she was focusing on the following fields of study:

Her primary areas of investigation include Cystic fibrosis, Cell biology, Cystic fibrosis transmembrane conductance regulator, Mutation and Chloride channel. Her Cystic fibrosis study improves the overall literature in Internal medicine. Her work carried out in the field of Cell biology brings together such families of science as Regulator, Transcription factor and Mutant.

Margarida D. Amaral has researched Cystic fibrosis transmembrane conductance regulator in several fields, including Cancer and Respiratory tree. Margarida D. Amaral works mostly in the field of Mutation, limiting it down to topics relating to Messenger RNA and, in certain cases, Western blot and Nonsense-mediated decay. Her Chloride channel research includes themes of Secretion, Signal transduction and Actin cytoskeleton.

Between 2017 and 2021, her most popular works were:

  • “CFTR Modulator Theratyping: Current Status, Gaps and Future Directions” (82 citations)
  • Compartmentalized crosstalk of CFTR and TMEM16A (ANO1) through EPAC1 and ADCY1 (20 citations)
  • R560S: A class II CFTR mutation that is not rescued by current modulators. (15 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • DNA

Margarida D. Amaral mainly investigates Cell biology, Cystic fibrosis, Cystic fibrosis transmembrane conductance regulator, Mutation and Endoplasmic reticulum. Her Chloride channel study, which is part of a larger body of work in Cell biology, is frequently linked to Calcineurin, bridging the gap between disciplines. Her work carried out in the field of Cystic fibrosis brings together such families of science as Basal and Genotype.

By researching both Cystic fibrosis transmembrane conductance regulator and Context, Margarida D. Amaral produces research that crosses academic boundaries. Her research integrates issues of Messenger RNA and Function in her study of Mutation. The Endoplasmic reticulum study combines topics in areas such as ER retention and Interactome.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene

Patrick R Sosnay;Karen R Siklosi;Fredrick Van Goor;Kyle Kaniecki;Kyle Kaniecki.
Nature Genetics (2013)

578 Citations

Progress in Therapies for Cystic Fibrosis

Kris De Boeck;Margarida D Amaral.
The Lancet Respiratory Medicine (2016)

347 Citations

Transcription-dependent spatial arrangements of CFTR and adjacent genes in human cell nuclei

Daniele Zink;Margarida D. Amaral;Andreas Englmann;Susanne Lang.
Journal of Cell Biology (2004)

310 Citations

Most F508del-CFTR is targeted to degradation at an early folding checkpoint and independently of calnexin.

Carlos M. Farinha;Margarida D. Amaral.
Molecular and Cellular Biology (2005)

223 Citations

Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis.

Anabela S. Ramalho;Sebastian Beck;Michelle Meyer;Deborah Penque.
American Journal of Respiratory Cell and Molecular Biology (2002)

198 Citations

New pharmacological approaches for cystic fibrosis: Promises, progress, pitfalls

Scott C. Bell;Kris De Boeck;Margarida D. Amaral.
Pharmacology & Therapeutics (2015)

194 Citations

CFTR and chaperones: processing and degradation.

Margarida D. Amaral.
Journal of Molecular Neuroscience (2004)

192 Citations

The human DnaJ homologue (Hdj)-1/heat-shock protein (Hsp) 40 co-chaperone is required for the in vivo stabilization of the cystic fibrosis transmembrane conductance regulator by Hsp70.

Carlos M. Farinha;Carlos M. Farinha;Paulo Nogueira;Filipa Mendes;Deborah Penque.
Biochemical Journal (2002)

181 Citations

Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis

Margarida D. Amaral;Karl Kunzelmann.
Trends in Pharmacological Sciences (2007)

179 Citations

“CFTR Modulator Theratyping: Current Status, Gaps and Future Directions”

John Paul Clancy;Calvin U. Cotton;Scott H. Donaldson;George M. Solomon.
Journal of Cystic Fibrosis (2019)

167 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Margarida D. Amaral

Marcus A. Mall

Marcus A. Mall

Charité - University Medicine Berlin

Publications: 38

Christine E. Bear

Christine E. Bear

University of Toronto

Publications: 37

Garry R. Cutting

Garry R. Cutting

Johns Hopkins University School of Medicine

Publications: 37

Karl Kunzelmann

Karl Kunzelmann

University of Regensburg

Publications: 36

Luis J. V. Galietta

Luis J. V. Galietta

Telethon Institute Of Genetics And Medicine

Publications: 33

Claude Férec

Claude Férec

University of Western Brittany

Publications: 31

Richard I. Morimoto

Richard I. Morimoto

Northwestern University

Publications: 30

Aleksander Edelman

Aleksander Edelman

Grenoble Alpes University

Publications: 29

Gergely L. Lukacs

Gergely L. Lukacs

McGill University

Publications: 28

Rainer Schreiber

Rainer Schreiber

University of Regensburg

Publications: 27

Paulo P. Freitas

Paulo P. Freitas

International Iberian Nanotechnology Laboratory

Publications: 27

Eric J. Sorscher

Eric J. Sorscher

Emory University

Publications: 27

Mireille Claustres

Mireille Claustres

University of Montpellier

Publications: 26

Philip M. Farrell

Philip M. Farrell

University of Wisconsin–Madison

Publications: 23

John R. Riordan

John R. Riordan

University of North Carolina at Chapel Hill

Publications: 23

Frédéric Becq

Frédéric Becq

University of Poitiers

Publications: 22

Trending Scientists

Jiming Chen

Jiming Chen

Zhejiang University

Srinivasan Damodaran

Srinivasan Damodaran

University of Wisconsin–Madison

R.Y. Hong

R.Y. Hong

Soochow University

Leland H. Johnston

Leland H. Johnston

Medical Research Council

Jeffrey N. Strathern

Jeffrey N. Strathern

National Institutes of Health

Bart Ghesquière

Bart Ghesquière

KU Leuven

Kazuro Shiomi

Kazuro Shiomi

Kitasato University

Galit Yovel

Galit Yovel

Tel Aviv University

Arne N. Akbar

Arne N. Akbar

University College London

Masayasu Kojima

Masayasu Kojima

Kurume University

James E. Montie

James E. Montie

University of Michigan–Ann Arbor

Demosthenes B. Panagiotakos

Demosthenes B. Panagiotakos

Harokopio University

Ian F. Pollack

Ian F. Pollack

University of Pittsburgh

John C. Hershey

John C. Hershey

University of Pennsylvania

Sue Thomas

Sue Thomas

Pacific Institute

Howard Brewington

Howard Brewington

New Mexico State University

Something went wrong. Please try again later.